#neoadjuvant — Tuesday, March 17, 2026 (1 items)
| 0 | ℹ |
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-03-17 | #immunity #cancer #immunotherapy #neoadjuvant |